ADHD

Gambling

Opioid Related Disorders

Alcohol Abuse

Amphetamine Related Disorders

Substance Use Disorder

Addiction & Substance Use

Disaster Psychiatry

Panic Disorder

Trauma And Violence

Traumatic Stress Disorders

Anxiety & Stress Disorders

Mania

Bipolar Disorder

COVID-19

Cannabis

Case Discussions

Child & Adolescent Psychiatry

Climate Change

Comorbidity

Compulsive Disorders

Cultural Psychiatry

Digital Therapeutics

Diversity, Equity, Inclusion

Eating Disorders

Emergency Psychiatry

Ethics

Munchausen Syndrome

Sexual Offenses

Forensic Psychiatry

Geriatric Psychiatry

Integrative Psychiatry

Major Depressive Disorder

Mental Health Awareness Month

Mood Disorders

Cognitive Disorders

Dementia

Alzheimer Disease

Autism

Neuropsychiatry

PTSD

Compulsive Personality Disorder

Dependent Personality Disorder

Dissociative Identity Disorder

Histrionic Personality Disorder

Schizoid Personality Disorder

Antisocial Personality Disorder

Borderline Personality

Personality Disorders

Psychedelics

Psychopharmacology

Delirium

Metabolic Disorders

Somatoform Disorder

Psychosomatics

Cognitive Behavioral Therapy

Psychotherapy

Paranoid Schizophrenia

Psychotic Affective Disorders

Schizoaffective

Schizophrenia Psychotic Features

Schizotypal Personality Disorder

Catatonic Schizophrenia

Schizophrenia/Psychosis

Nocturnal Paroxysmal Dystonia

Sleep Deprivation

Sleep Wake Transition

Circadian Rhythm Sleep Disorders

Sleep Disorders

Pervasive Developmental Disorder

Gender Issues

Military Mental Health

Special Populations

Suicide

Tardive Dyskinesia

Technology & Psychiatry

Transcranial Magnetic Stimulation

News

Media

Around the Practice

Between the Lines

PsychView

Expert Perspectives

Case-Based Psych Perspectives

Dialogues

Payer-Provider Perspective

Slideshows

Videos

Viewpoints

Conferences

Conference Coverage

Conference Listing

Publication

Psychiatric Times

Job Board

CME/CE

Partners

Editorial

Resources

Clinical Scales

Interactive Tools

Quizzes

Series

Special Reports

Subscribe

Articles

"In the face of such a pervasive crisis, being present for those with addiction can ignite hope and foster healing."

Enduring the Weight of Addiction in Clinical Practice

Check out new positive topline data from the SAVITRI study assessing the efficacy and safety of NBI-1065845 in adults with major depressive disorder.

Positive Phase 2 Data for NBI-1065845 in Adults With Major Depressive Disorder

While benzodiazepine prescribing certainly carries risks, those risks have been demonstrably exaggerated in the minds of government officials, critics, and the public at large.

Benzodiazepines: Fellow Psychiatrists, We Still Have Work to Do

is an award-winning psychiatrist who specialized in the cultural and ethical aspects of psychiatry, and is now in retirement and refirement as a private pro bono community psychiatrist. A prolific writer and speaker, he has done a weekday column titled “Psychiatric Views on the Daily News” and a weekly video, “Psychiatry & Society,” since the COVID-19 pandemic emerged. He was chosen to receive the 2024 Abraham Halpern Humanitarian Award from the American Association for Social Psychiatry. Previously, he received the Administrative Award in 2016 from the American Psychiatric Association, the one-time designation of being a Hero of Public Psychiatry from the Speaker of the Assembly of the APA in 2002, and the Exemplary Psychiatrist Award from the National Alliance for the Mentally Ill in 1991. He is an advocate and activist for mental health issues related to climate instability, physician burnout, and xenophobia. He is now editing the final book in a 4-volume series on religions and psychiatry for Springer: Islamophobia, anti-Semitism, Christianity, and now

How have the advancements of television and the internet changed our perception of war?

Our Revolutions Are Being Televised

Advertise

Contact Us

Terms and Conditions

Privacy Policy

Do Not Sell My Personal Information

Twitter

Facebook

LinkedIn

Spotlight

Expert Perspectives on the Unmet Needs in the Management of Major Depressive Disorder

Schizophrenia/Psychosis 

Commentary

Couch In Crisis

Early Career Psychiatry

History of Psychiatry

Residents Corner

Cultural Corner

Film and Book Reviews

Poetry

Writers Contest

Psychiatric Practice

Burnout

Careers

Coding

Guidelines

Risk Management

Telepsychiatry

Critical Conversations in Psychiatry

Portraits

Psychiatric Views on the Daily News

Tales from the New Asylum

1rem

Authors

is the Semmes Foundation Distinguished University Chair in Neurobiology at the University of Texas, 

The FDA approval of aducanumab has given hope to millions of patients with Alzheimer disease—but will it live up to the hype?  

A Skeptical Look at Aducanumab

George Perry, PhD

Articles